The effectiveness of exercise-based interventions on muscle mass, muscle strength, functional performance, aerobic capacity, and health-related quality of life in adults with malignant lymphoma undergoing chemotherapy: a systematic review of randomized controlled trials
DOI:
https://doi.org/10.2340/1651-226X.2025.42056Keywords:
Lymphomas, Hematology, Chemotherapy, Exercise, Physical activityAbstract
Purpose: This study aims to identify and summarize evidence on the effectiveness of exercise-based interventions on muscle mass, muscle strength, functional performance, aerobic capacity, health-related quality of life (HRQoL), feasibility of the interventions, in patients with malignant lymphoma undergoing chemotherapy.
Methods: A systematic search was conducted in six electronic databases and trials registers on November 15, 2023. Peer-reviewed randomized controlled trials (RCTs) comparing exercise intervention with controls/usual care in adults (≥18 years) diagnosed with Hodgkin’s lymphoma and non-Hodgkin’s lymphoma undergoing chemotherapy were considered for inclusion. All study authors were contacted to obtain unpublished subgroup data. Two reviewers independently screened and extracted data and assessed the quality of evidence using the revised Cochrane risk-of-bias tool for randomized trials.
Results: Six RCTs published between 2009 and 2021, with 838 participants, were included. Due to clinical heterogeneity, a meta-analysis was not feasible, therefore the results were synthesized narratively. Exercise interventions during treatment were found to be feasible with few adverse events reported. The included studies indicate positive effects of exercise during chemotherapy on muscle mass, muscle strength, functional performance, aerobic capacity, and HRQoL compared to usual care.
Interpretation: Despite extensive search criteria, a limited number of heterogenous studies were eligible, which may explain the very low certainty of evidence for all outcomes. Nonetheless, exercise-based interventions conducted during treatment were feasible, safe and potentially effective. Further studies are needed to guide future exercise recommendations for these patients.
Downloads
References
Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IBO, Berti E, et al. The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia. 2022;36(7):1720–48.
https://doi.org/10.1038/s41375-022-01620-2 DOI: https://doi.org/10.1038/s41375-022-01620-2
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.
https://doi.org/10.3322/caac.21660 DOI: https://doi.org/10.3322/caac.21660
Pilleron S, Sarfati D, Janssen-Heijnen M, Vignat J, Ferlay J, Bray F, et al. Global cancer incidence in older adults, 2012 and 2035: a population-based study. Int J Cancer. 2019;144(1):49–58.
https://doi.org/10.1002/ijc.31664 DOI: https://doi.org/10.1002/ijc.31664
Howlader N, Noone A, Krapcho M, Miller D, Brest A, Yu M, et al. SEER cancer statistics review. National Cancer Institute. Available from: https://seer.cancer.gov/csr/1975_2018/ based on November 2020 SEER data submission, posted to the SEER web site, April 2021. [Cited date: 12.03.2024]
Vega MC, Laviano A, Pimentel GD. Sarcopenia and chemotherapy-mediated toxicity. Einstein. 2016;14(4):580–4.
https://doi.org/10.1590/s1679-45082016md3740 DOI: https://doi.org/10.1590/s1679-45082016md3740
Tanaka S, Imataki O, Kitaoka A, Fujioka S, Hanabusa E, Ohbayashi Y, et al. Clinical impact of sarcopenia and relevance of nutritional intake in patients before and after allogeneic hematopoietic stem cell transplantation. J Cancer Res Clin Oncol. 2017;143(6):1083–92.
https://doi.org/10.1007/s00432-016-2336-8 DOI: https://doi.org/10.1007/s00432-016-2336-8
Go SI, Park MJ, Song HN, Kim HG, Kang MH, Lee HR, et al. Prognostic impact of sarcopenia in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone. J Cachexia Sarcopenia Muscle. 2016;7(5):567–76.
https://doi.org/10.1002/jcsm.12115 DOI: https://doi.org/10.1002/jcsm.12115
Nakamura N, Hara T, Shibata Y, Matsumoto T, Nakamura H, Ninomiya S, et al. Sarcopenia is an independent prognostic factor in male patients with diffuse large B-cell lymphoma. Ann Hematol. 2015;94(12):2043–53.
https://doi.org/10.1007/s00277-015-2499-4 DOI: https://doi.org/10.1007/s00277-015-2499-4
Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16–31.
https://doi.org/10.1093/ageing/afy169 DOI: https://doi.org/10.1093/ageing/afy169
Anjanappa M, Corden M, Green A, Roberts D, Hoskin P, McWilliam A, et al. Sarcopenia in cancer: risking more than muscle loss. Tech Innov Patient Support Radiat Oncol. 2020;16:50–7.
https://doi.org/10.1016/j.tipsro.2020.10.001 DOI: https://doi.org/10.1016/j.tipsro.2020.10.001
Pedersen BK, Saltin B. Exercise as medicine – evidence for prescribing exercise as therapy in 26 different chronic diseases. Scand J Med Sci Sports. 2015;25(Suppl. 3):1–72.
https://doi.org/10.1111/sms.12581 DOI: https://doi.org/10.1111/sms.12581
Campbell KL, Winters-Stone KM, Wiskemann J, May AM, Schwartz AL, Courneya KS, et al. Exercise guidelines for cancer survivors: consensus statement from international multidisciplinary roundtable. Med Sci Sports Exerc. 2019;51(11):2375–90.
https://doi.org/10.1249/MSS.0000000000002116 DOI: https://doi.org/10.1249/MSS.0000000000002116
Loughney LA, West MA, Kemp GJ, Grocott MP, Jack S. Exercise interventions for people undergoing multimodal cancer treatment that includes surgery. Cochrane Database Syst Rev. 2018;12(12):Cd012280.
https://doi.org/10.1002/14651858.CD012280.pub2 DOI: https://doi.org/10.1002/14651858.CD012280.pub2
Amatya B, Khan F, Lew TE, Dickinson M. Rehabilitation in patients with lymphoma: an overview of systematic reviews. J Rehabil Med. 2021;53(3):jrm00163.
https://doi.org/10.2340/16501977-2810 DOI: https://doi.org/10.2340/16501977-2810
AlJohi AA, Aljehani GH, AlSaeed SA, Alhoqail H, Mohammed J, Madi SM. Evidence-based exercises intervention in adults diagnosed with Lymphoma. Saudi Med J. 2022;43(5):441–50.
https://doi.org/10.15537/smj.2022.43.5.20210894 DOI: https://doi.org/10.15537/smj.2022.43.5.20210894
Higgins J, Thomas J, Chandler J, Cumpston M, Li T, Page M, et al. Cochrane handbook for systematic reviews of interventions version 6.3 (updated February 2022). 2022. Available from: www.training.cochrane.org/handbook [Cited date: 21.07.2023]
Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;372:n160.
https://doi.org/10.1136/bmj.n160 DOI: https://doi.org/10.1136/bmj.n160
Campbell M, McKenzie JE, Sowden A, Katikireddi SV, Brennan SE, Ellis S, et al. Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline. BMJ. 2020;368:l6890.
https://doi.org/10.1136/bmj.l6890 DOI: https://doi.org/10.1136/bmj.l6890
Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.
https://doi.org/10.1136/bmj.l4898 DOI: https://doi.org/10.1136/bmj.l4898
Altman DG, Bland JM. How to obtain the confidence interval from a P value. BMJ. 2011;343:d2090.
https://doi.org/10.1136/bmj.d2090 DOI: https://doi.org/10.1136/bmj.d2090
Adamsen L, Quist M, Andersen C, Møller T, Herrstedt J, Kronborg D, et al. Effect of a multimodal high intensity exercise intervention in cancer patients undergoing chemotherapy: randomised controlled trial. BMJ. 2009;339:b3410.
https://doi.org/10.1136/bmj.b3410 DOI: https://doi.org/10.1136/bmj.b3410
Arrieta H, Astrugue C, Regueme S, Durrieu J, Maillard A, Rieger A, et al. Effects of a physical activity programme to prevent physical performance decline in onco-geriatric patients: a randomized multicentre trial. J Cachexia Sarcopenia Muscle. 2019;10(2):287–97.
https://doi.org/10.1002/jcsm.12382 DOI: https://doi.org/10.1002/jcsm.12382
Courneya KS, Sellar CM, Stevinson C, McNeely ML, Peddle CJ, Friedenreich CM, et al. Randomized controlled trial of the effects of aerobic exercise on physical functioning and quality of life in lymphoma patients. J Clin Oncol. 2009;27(27):4605–12.
https://doi.org/10.1200/JCO.2008.20.0634 DOI: https://doi.org/10.1200/JCO.2008.20.0634
Oechsle K, Aslan Z, Suesse Y, Jensen W, Bokemeyer C, de Wit M. Multimodal exercise training during myeloablative chemotherapy: a prospective randomized pilot trial. Support Care Cancer. 2014;22(1):63–9.
https://doi.org/10.1007/s00520-013-1927-z DOI: https://doi.org/10.1007/s00520-013-1927-z
Streckmann F, Kneis S, Leifert JA, Baumann FT, Kleber M, Ihorst G, et al. Exercise program improves therapy-related side-effects and quality of life in lymphoma patients undergoing therapy. Ann Oncol. 2014;25(2):493–9.
https://doi.org/10.1093/annonc/mdt568 DOI: https://doi.org/10.1093/annonc/mdt568
Munsie C, Ebert J, Joske D, Ackland T. A randomised controlled trial investigating the ability for supervised exercise to reduce treatment-related decline in adolescent and young adult cancer patients. Support Care Cancer. 2022;30(10):8159–71.
https://doi.org/10.1007/s00520-022-07217-w DOI: https://doi.org/10.1007/s00520-022-07217-w
Buffart LM, Kalter J, Sweegers MG, Courneya KS, Newton RU, Aaronson NK, et al. Effects and moderators of exercise on quality of life and physical function in patients with cancer: an individual patient data meta-analysis of 34 RCTs. Cancer Treat Rev. 2017;52:91–104.
https://doi.org/10.1016/j.ctrv.2016.11.010 DOI: https://doi.org/10.1016/j.ctrv.2016.11.010
Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF, Blazer DG, et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol. 1994;49(2):M85–94.
https://doi.org/10.1093/geronj/49.2.M85 DOI: https://doi.org/10.1093/geronj/49.2.M85
Toohey K, Hunter M, Paterson C, Mortazavi R, Singh B. Exercise adherence in men with prostate cancer undergoing androgen deprivation therapy: a systematic review and meta-analysis. Cancers (Basel). 2022;14(10):2452.
https://doi.org/10.3390/cancers14102452 DOI: https://doi.org/10.3390/cancers14102452
Singh B, Spence R, Steele ML, Hayes S, Toohey K. Exercise for individuals with lung cancer: a systematic review and meta-analysis of adverse events, feasibility, and effectiveness. Semin Oncol Nurs. 2020;36(5):151076.
https://doi.org/10.1016/j.soncn.2020.151076 DOI: https://doi.org/10.1016/j.soncn.2020.151076
Purdy GM, Nanad R, Ternes L, Dolgoy ND, Sellar CM, Francis G, et al. Exercise preferences, barriers, and facilitators of individuals with cancer undergoing chemotherapy before stem cell transplantation: a mixed-methods study. Cancer Nurs. 2024;47(5):E287–97.
https://doi.org/10.1097/NCC.0000000000001240 DOI: https://doi.org/10.1097/NCC.0000000000001240
Vermaete N, Wolter P, Verhoef G, Gosselink R. Physical activity, physical fitness and the effect of exercise training interventions in lymphoma patients: a systematic review. Ann Hematol. 2013;92(8):1007–21.
https://doi.org/10.1007/s00277-013-1689-1 DOI: https://doi.org/10.1007/s00277-013-1689-1
Additional Files
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2025 Charlotte Groenset, Magnus N. Bech, Mary Jarden, Nina Høgdal, Martin Hutchings, Charlotte Suetta, Jan Christensen
This work is licensed under a Creative Commons Attribution 4.0 International License.
